Head-to-Head Comparison
| Criteria | Saw Palmetto | Beta-Sitosterol for Prostate | Winner |
|---|---|---|---|
| BPH Symptom Relief (IPSS) | Mixed — early positive trials, but STEP and CAMUS trials showed no benefit | Positive — Cochrane review of 4 RCTs found significant IPSS improvement | Beta-Sitosterol for Prostate |
| Urinary Flow Improvement | Inconsistent — no significant Qmax improvement in large trials | Moderate — mean Qmax improvement of 3.91 mL/s over placebo | Beta-Sitosterol for Prostate |
| Side Effects | Excellent — very well tolerated, comparable to placebo | Excellent — very well tolerated, rare GI complaints | Tie |
| Research Quality | High — large rigorous RCTs (STEP, CAMUS) but negative results | Moderate — positive Cochrane review but smaller, older trials | Tie |
| Cost & Availability | $0.10-0.30/day — widely available | $0.20-0.50/day — less common as standalone | Saw Palmetto |